Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Enver Akalin

Showing results (11-20 of 137) with videos related to

Pageof 14
Sort By:
Kidney International|February 14, 2002
Gene therapy and solid-organ transplantationEnver Akalin, Jonathan S Bromberg
Kidney International. Supplement|December 1, 2010
Genomics of chronic allograft injuryEnver Akalin, Philip J O'Connell
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 4, 2023
Inside look: Are noninvasive biomarkers up to standard?Enver Akalin, Valeria R Mas
Transplantation|June 7, 2003
The influence of Duffy blood group on renal allograft outcome in African AmericansEnver Akalin, John F Neylan
P & T : a Peer-Reviewed Journal for Formulary Management|November 14, 2013
Clinical outcomes after conversion from brand-name tacrolimus (prograf) to a generic formulation in renal transplant recipients: a retrospective cohort studyKwaku Marfo, Samuel Aitken, Enver Akalin
Current Opinion in Organ Transplantation|April 14, 2010
Combined liver and kidney transplantationHaris Papafragkakis, Paul Martin, Enver Akalin
Clinical Journal of the American Society of Nephrology : CJASN|March 29, 2011
Desensitization protocols and their outcomeKwaku Marfo, Amy Lu, Min Ling, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 19, 2011
Clinical and economic analysis of short-course versus standard-course antithymocyte globulin (rabbit) induction therapy in deceased-donor renal transplant recipientsKwaku Marfo, Enver Akalin, Cuiling Wang, et al.
Transplantation|January 25, 2005
Intravenous immunoglobulin treatment in a kidney transplant patient with chronic allograft nephropathyEnver Akalin, Vinita Sehgal, Barbara Murphy, et al.
Transplantation|September 16, 2008
Hyperuricemia is associated with the development of the composite outcomes of new cardiovascular events and chronic allograft nephropathyEnver Akalin, Sri Venkatesh Ganeshan, Jonathan Winston, et al.
Pageof 14

Showing results (11-20 of 137) with videos related to

Sort By:
Pageof 14
Kidney International|February 14, 2002
Gene therapy and solid-organ transplantationEnver Akalin, Jonathan S Bromberg
Kidney International. Supplement|December 1, 2010
Genomics of chronic allograft injuryEnver Akalin, Philip J O'Connell
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 4, 2023
Inside look: Are noninvasive biomarkers up to standard?Enver Akalin, Valeria R Mas
Transplantation|June 7, 2003
The influence of Duffy blood group on renal allograft outcome in African AmericansEnver Akalin, John F Neylan
P & T : a Peer-Reviewed Journal for Formulary Management|November 14, 2013
Clinical outcomes after conversion from brand-name tacrolimus (prograf) to a generic formulation in renal transplant recipients: a retrospective cohort studyKwaku Marfo, Samuel Aitken, Enver Akalin
Current Opinion in Organ Transplantation|April 14, 2010
Combined liver and kidney transplantationHaris Papafragkakis, Paul Martin, Enver Akalin
Clinical Journal of the American Society of Nephrology : CJASN|March 29, 2011
Desensitization protocols and their outcomeKwaku Marfo, Amy Lu, Min Ling, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 19, 2011
Clinical and economic analysis of short-course versus standard-course antithymocyte globulin (rabbit) induction therapy in deceased-donor renal transplant recipientsKwaku Marfo, Enver Akalin, Cuiling Wang, et al.
Transplantation|January 25, 2005
Intravenous immunoglobulin treatment in a kidney transplant patient with chronic allograft nephropathyEnver Akalin, Vinita Sehgal, Barbara Murphy, et al.
Transplantation|September 16, 2008
Hyperuricemia is associated with the development of the composite outcomes of new cardiovascular events and chronic allograft nephropathyEnver Akalin, Sri Venkatesh Ganeshan, Jonathan Winston, et al.
Pageof 14